Abstract:OBJECTIVE:To detect the quantity, proportion and function of producing cytokines of Th1 and Th2 cells in aplastic anemia (AA) patients and their contribution to the hematopoietic failure.METHODS:(1) Eleven patients with severe aplastic anemia (SAA) at diagnosis were observed by Marsh's method for the CFU-E, BFU-E and CFU-GM before and after depletion of CD(4)(+) T lymphocytes from bone marrow mononuclear cells (BMMNC); (2) Th1 (CD(4)(+) IFN-gamma(+)) and Th2 (CD(4)(+) IL-4(+)) cells in peripheral blood mononuclear cells (PBMNC) of 21 SAA patients and 17 normal controls were counted by FACS. (3) mRNA expression of IFN-gamma and IL-4 gene in unstimulated BMMNC from 16 SAA patients, 11 chronic aplastic anemia (CAA) patients, 26 other hematological diseases patients and 11 normal controls were measured by reverse transcriptase polymerase chain reaction (RT-PCR).RESULT:(1) CFU-E, CFU-GM and BFU-E increased significantly after depletion of CD(4)(+) T lymphocytes from BMMNC of SAA patients. (2) The percentage of IFN-gamma producing CD(4)(+) T cell (Th1) of SAA patients was significantly higher than that of controls, the percentages of IL-4 producing CD(4)(+) T cells (Th2) had no difference between SAA patients and normal controls. (3) IFN-gamma mRNA was detected in unstimulated BMMNC in 13 of 16 SAA patients, 6 of 11 CAA patients and one of 6 paroxysmal nocturnal hemoglobinuria (PNH) patients. The IFN-gamma mRNA was not detected in unstimulated BMMNC of 11 normal controls and other hematological diseases patients.CONCLUSIONS:Disbalance of CD(4)(+) T lymphocytes subsets and increases in quantity and IFN-gamma producing function of Th1 cells might be important for the development of bone marrow failure in AA and in distinguishing AA from other kinds of pancytopenic diseases.

Detection of soluble CD40L level in peripheral blood and bone marrow of patients with aplastic anemia

Alteration of Soluble CD40L Level in Serum of Patients with Aplastic Anemia and Its Impact on the Apoptosis of Normal Monocytes

Effects of Immunological Factors on Pathogenesis of Aplastic Anemia and Its Clinical Significane

DETECTION OF FLT3-LIGAND LEVEL IN THE BONE MARROW AND PERIPHERAL BLOOD OF THE PATIENTS WITH APLASTIC ANEMIA AND ITS SIGNIFICANCE

Increased bone marrow (BM) plasma level of soluble CD30 and correlations with BM plasma level of interferon (IFN)-γ, CD4/CD8 T-cell ratio and disease severity in aplastic anemia.

Increased Bone Marrow (Bm) Plasma Level Of Soluble Cd30 And Correlations With Bm Plasma Level Of Interferon (Ifn)-Gamma, Cd4/Cd8 T-Cell Ratio And Disease Severity In Aplastic Anemia

A study on T - cell subgroup in peripheral blood of children with aplastic anemia

Analysis of Peripheral T-Lymphocytic Cell Phenotypes in Children with Aplastic Anemia

Significance of Changes of FL Concentrations in Bone Marrow and Peripheral Blood of Patients with Aplastic Anemia

[Study on the Cellular Immune Function and Cytokines in Aplastic Anemia Patients].

[Role of Th1 Cell in the Pathogenesis of Aplastic Anemia].

Application of terminal effect T cell subgroup to preparation of kit for assisting in evaluating degree of illness of aplastic anemia (AA)

Abnormal Expressed Co-Stimulating Factors and Their Relationship to Activation of T Lymphocytes in Patients with Aplastic Anemia

Study on bone marrow angiogenic mediators and inhibitors in aplastic anemia

Comparative Proteomic Analysis of CD34+ Cells in Bone Marrow Between Severe Aplastic Anemia and Normal Control

Cd8(+)Hla-Dr+ T Cells Are Increased in Patients with Severe Aplastic Anemia

Dysregulated T-cell homeostasis and decreased CD30+ Treg proliferating in aplastic anemia

Changes and Clinical Significances of CD4~+T Cell Subsets in Aplastic Anemia, Myelodysplastic Syndromes and Acute Myeloid Leukemia Patients

Abnormality Of Lymphotoxin Alpha In Cd8+T Cells Of Patients With Severe Aplastic Anemia

Comparison of T lymphocyte subsets in aplastic anemia and hypoplastic myelodysplastic syndromes

Increased CD8+CD27+perforin+ T Cells and Decreased CD8+CD70+ T Cells May Be Immune Biomarkers for Aplastic Anemia Severity.